187 related articles for article (PubMed ID: 9624494)
1. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
Franceschini N; Perilli M; Segatore B; Setacci D; Amicosante G; Mazzariol A; Cornaglia G
Antimicrob Agents Chemother; 1998 Jun; 42(6):1459-62. PubMed ID: 9624494
[TBL] [Abstract][Full Text] [Related]
2. TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.
Piccirilli A; Perilli M; Amicosante G; Conte V; Tascini C; Rossolini GM; Giani T
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941651
[TBL] [Abstract][Full Text] [Related]
3. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
Poirel L; Mammeri H; Nordmann P
Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
[TBL] [Abstract][Full Text] [Related]
4. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Livermore DM; Yuan M
J Antimicrob Chemother; 1996 Sep; 38(3):409-24. PubMed ID: 8889716
[TBL] [Abstract][Full Text] [Related]
6. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
Luzzaro F; Perilli M; Amicosante G; Lombardi G; Belloni R; Zollo A; Bianchi C; Toniolo A
Int J Antimicrob Agents; 2001 Feb; 17(2):131-5. PubMed ID: 11165117
[TBL] [Abstract][Full Text] [Related]
7. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
[TBL] [Abstract][Full Text] [Related]
8. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.
Kitzis MD; Billot-Klein D; Goldstein FW; Williamson R; Tran Van Nhieu G; Carlet J; Acar JF; Gutmann L
Antimicrob Agents Chemother; 1988 Jan; 32(1):9-14. PubMed ID: 2831817
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
Rice LB; Carias LL; Bonomo RA; Shlaes DM
J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
[TBL] [Abstract][Full Text] [Related]
12. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
Thomson CJ; Amyes SG
J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
[TBL] [Abstract][Full Text] [Related]
13. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
[TBL] [Abstract][Full Text] [Related]
14. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
[TBL] [Abstract][Full Text] [Related]
15. First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6')-Ib-cr determinants.
Mahrouki S; Chihi H; Bourouis A; Ben Moussa M; Belhadj O
Braz J Infect Dis; 2014; 18(2):211-4. PubMed ID: 24378226
[TBL] [Abstract][Full Text] [Related]
16. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
[TBL] [Abstract][Full Text] [Related]
17. First detection of TEM-116 extended-spectrum β-lactamase in a Providencia stuartii isolate from a Tunisian hospital.
Lahlaoui H; Dahmen S; Moussa MB; Omrane B
Indian J Med Microbiol; 2011; 29(3):258-61. PubMed ID: 21860106
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.
Bonnefoy A; Dupuis-Hamelin C; Steier V; Delachaume C; Seys C; Stachyra T; Fairley M; Guitton M; Lampilas M
J Antimicrob Chemother; 2004 Aug; 54(2):410-7. PubMed ID: 15254025
[TBL] [Abstract][Full Text] [Related]
19. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.
Caniça MM; Barthélémy M; Gilly L; Labia R; Krishnamoorthy R; Paul G
Antimicrob Agents Chemother; 1997 Feb; 41(2):374-8. PubMed ID: 9021194
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R
Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
